GTBP vs VRTX: Which Stock is Better?

Side-by-side comparison of GT Biopharma Inc and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

GTBP

GT Biopharma Inc

VRTX

Vertex Pharmaceuticals Inc

$476.31

Key Metrics Comparison

MetricGTBPVRTXWinner
Market Cap$17.43M$106.87BVRTX
P/E RatioN/A29.67VRTX
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze GTBP

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is GTBP or VRTX a better investment?

Comparing GTBP and VRTX: GT Biopharma Inc has a market cap of $17.43M while Vertex Pharmaceuticals Inc has $106.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between GTBP and VRTX?

GTBP (GT Biopharma Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: GTBP or VRTX?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: GTBP or VRTX?

Both GTBP and VRTX show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: GTBP or VRTX?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: GTBP or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $106.87B compared to $17.43M for GTBP.

Should I buy GTBP or VRTX in 2026?

Both GTBP and VRTX have investment merit. GTBP trades at $N/A while VRTX trades at $476.31. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between GTBP and VRTX stock?

Key differences: Market Cap ($17.43M vs $106.87B), P/E Ratio (N/A vs 29.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy GTBP or VRTX in 2026?

The choice between GTBP and VRTX depends on your investment goals. VRTX shows higher revenue growth (0.0%). VRTX has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between GTBP and VRTX?

GTBP (GT Biopharma Inc) has a market cap of $17.43M, while VRTX (Vertex Pharmaceuticals Inc) has a market cap of $106.87B. VRTX is the larger company by market value.

Popular Stock Comparisons